{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:29:18Z","timestamp":1788262158189,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clml.2023.11.011","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T02:49:09Z","timestamp":1702349349000},"page":"214-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: \u201cPer Aspera Ad Astra\u201d"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5228-6491","authenticated-orcid":false,"given":"Elisabetta","family":"Abruzzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata Monika","family":"Trawinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"De Fabritiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2023.11.011_bib0001","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3390\/jcm9061709","article-title":"Chronic myeloid leukemia prognosis and therapy: criticisms and perspectives","volume":"9","author":"Russo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/ejh.13192","article-title":"Back to the future: treatment-free remission and pregnancy in chronic myeloid leukemia","volume":"102","author":"Abruzzese","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0003","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.leukres.2005.01.009","article-title":"Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML): outcome of discontinuation of imatinib therapy after achieving a molecular remission","volume":"29","author":"Ali","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0004","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/10428194.2016.1201571","article-title":"Pregnancy: part of life in chronic myelogenous leukemia","volume":"58","author":"Law","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.11.011_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase: role and significance in cancer","volume":"1","author":"Paul","year":"2004","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.clml.2023.11.011_bib0006","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clml.2023.11.011_bib0007","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.028","article-title":"Tyrosine kinase inhibitors and pregnancy","volume":"6","author":"Abruzzese","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2023.11.011_bib0008","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/cpt.813","article-title":"Tyrosine kinase inhibitors and male reproductive health","volume":"102","author":"Ramstein","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clml.2023.11.011_bib0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00404-010-1501-6","article-title":"Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib","volume":"283","author":"Oweini","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clml.2023.11.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243045","article-title":"Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a systematic review","volume":"15","author":"Szak\u00e1cs","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2023.11.011_bib0011","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","article-title":"The effects of imatinib on pregnancy outcome","volume":"111","author":"Pye","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0035-1556745","article-title":"Prenatal exposures and short and long term developmental outcomes: identifying human teratogens: an update","volume":"4","author":"Alwan","year":"2015","journal-title":"J Pediatr Genet"},{"key":"10.1016\/j.clml.2023.11.011_bib0013","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17474086.2016.1205479","article-title":"Management of pregnant chronic myeloid leukemia patients","volume":"9","author":"Abruzzese","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/hematology.2022000330","article-title":"Treatment of CML in pregnancy","volume":"2022","author":"Robertson","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2023.11.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720966120","article-title":"Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations","volume":"11","author":"Abruzzese","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11899-023-00689-5","article-title":"Family planning and pregnancy in patients with chronic myeloid leukemia","volume":"18","author":"Berman","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2023.11.011_bib0017","article-title":"Management of chronic myeloid leukemia and pregnancy: a bibliometric analysis (2000-2020)","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0018","first-page":"102","article-title":"Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia","volume":"35","author":"Norhaya","year":"1994","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clml.2023.11.011_bib0019","first-page":"487","article-title":"Full-term pregnancy with embryos from donated oocytes in a 36-year-old woman allografted for chronic myeloid leukemia","volume":"13","author":"Rio","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.11.011_bib0020","doi-asserted-by":"crossref","unstructured":"Lipton, J.H.; Virro, M.; Solow, H. Successful pregnancy after allogeneic bone marrow transplant with embryos isolated before transplant. J Clin Oncol 2016, 15, 3347\u20133349, doi:10.1200\/JCO.1997.15.11.3347.","DOI":"10.1200\/JCO.1997.15.11.3347"},{"key":"10.1016\/j.clml.2023.11.011_bib0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0609.1996.tb00497.x","article-title":"Two cases of CML treated with alpha- interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum","volume":"57","author":"Haggstrom","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<119::AID-HON576>3.0.CO;2-Q","article-title":"Alpha-interferon and pregnancy in a patient with CML","volume":"14","author":"Lipton","year":"1996","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajh.9876","article-title":"Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-\u03b1 in 1st trimester: report of 3 cases and review of the literature","volume":"69","author":"Mubarak","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-3693-0","article-title":"Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature","volume":"5","author":"Sheng","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.clml.2023.11.011_bib0025","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2015.020","article-title":"Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib : a case report and a review","volume":"7","author":"Santorsola","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2023.11.011_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/0971-5851.89795","article-title":"An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib","volume":"32","author":"Martin","year":"2011","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/136252","article-title":"Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy","volume":"2010","author":"Conchon","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0028","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s10815-020-01907-2","article-title":"Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia","volume":"37","author":"Rios","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.clml.2023.11.011_bib0029","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5505\/tjh.2012.82542","article-title":"Imatinib use in pregnancy","volume":"29","author":"Webb","year":"2012","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0030","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.leukres.2008.09.012","article-title":"Persistence of molecular remission throughout pregnancy in CML after imatinib","volume":"33","author":"Sor\u00e0","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0031","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5144\/0256-4947.2015.468","article-title":"Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports","volume":"35","author":"Alizadeh","year":"2015","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0032","first-page":"1","article-title":"Recurrence of chronic myeloid leukemia during pregnancy subsequently achieving complete medical remission","volume":"2017","author":"Mikhael","year":"2017","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0033","article-title":"Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: case report and literature review","volume":"12","author":"Furukawa","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2023.11.011_bib0034","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000506590","article-title":"Outcome of pregnancy in the era of pegylated interferon-\u03912a in females with chronic myeloid leukemia: an experience from Qatar","volume":"13","author":"Abu-Tineh","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3138718","article-title":"Chronic myeloid leukemia and cesarean section: the anesthesiologist's point of view","volume":"2018","author":"Rebahi","year":"2018","journal-title":"Case Rep Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.clml.2023.11.011_bib0036","first-page":"259","article-title":"Two consecutive twin and a singleton pregnancy in a patient with chronic myeloid leukemia","volume":"10","author":"Halim","year":"2014","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0037","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.leukres.2008.03.007","article-title":"Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy","volume":"32","author":"Meera","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0038","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2169\/internalmedicine.48.2084","article-title":"Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib","volume":"48","author":"Tsuzuki","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0039","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.21873\/invivo.11641","article-title":"Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib","volume":"33","author":"Stella","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.clml.2023.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/624590","article-title":"Planned pregnancy in a chronic myeloid leukemia patient in molecular remission","volume":"2012","author":"Pavlovsky","year":"2012","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0041","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5507\/bp.2008.019","article-title":"Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy","volume":"152","author":"Skoumalova","year":"2008","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.clml.2023.11.011_bib0042","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.10935","article-title":"Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib","volume":"92","author":"Garderet","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.11.011_bib0043","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.027","article-title":"Breastfeeding in patients with chronic myeloid leukaemia: case series with measurements of drug concentrations in maternal milk and review of literature","volume":"10","author":"Chelysheva","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2023.11.011_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-2-42","article-title":"Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study","volume":"2","author":"Conchon","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2169\/internalmedicine.48.1687","article-title":"Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia","volume":"48","author":"Kobayashi","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0046","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/hematolrep14010008","article-title":"Outcomes of the pregnancies with chronic myeloid leukemia in the tyrosine kinase inhibitor era and literature review","volume":"14","author":"Castillo","year":"2022","journal-title":"Hematol Rep"},{"key":"10.1016\/j.clml.2023.11.011_bib0047","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ajh.24186","article-title":"The impact of dasatinib on pregnancy outcomes","volume":"90","author":"Cortes","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0048","doi-asserted-by":"crossref","first-page":"IJH26","DOI":"10.2217\/ijh-2020-0004","article-title":"Pregnancy outcomes in patients treated with bosutinib","volume":"9","author":"Cortes","year":"2020","journal-title":"Int J Hematol Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0049","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/jcm11071801","article-title":"Chronic myeloid leukemia and pregnancy: when dreams meet reality. state of the art, management and outcome of 41 cases, nilotinib placental transfer","volume":"11","author":"Abruzzese","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2018-99-118908","article-title":"Gimema registry of conception\/pregnancy in adult italian patients diagnosed with chronic myeloid leukemia (CML): report on 166 outcomes","volume":"132","author":"Abruzzese","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0051","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1200\/JCO.2005.04.6557","article-title":"Pregnancy among patients with chronic myeloid leukemia treated with imatinib","volume":"24","author":"Ault","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0052","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.htct.2018.10.001","article-title":"Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center","volume":"41","author":"Moura","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.clml.2023.11.011_bib0053","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hemonc.2014.03.001","article-title":"Leukemia during pregnancy: long term follow up of 32 cases from a single institution","volume":"7","author":"Saleh","year":"2014","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.clml.2023.11.011_bib0054","first-page":"1","article-title":"Pregnancy outcomes in chronic myeloid leukemia: a single center experience","volume":"2019","author":"Madabhavi","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0055","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.leukres.2009.05.012","article-title":"Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery","volume":"33","author":"Klamov\u00e1","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0056","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00277-023-05280-9","article-title":"Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an indian tertiary care institution","volume":"102","author":"R","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0057","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/10428194.2020.1849672","article-title":"Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-center experience","volume":"62","author":"Assi","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.11.011_bib0058","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.HS9.0000561804.14876.ab","article-title":"Pregnancy outcome in female patients with chronic myeloid leukemia worldwide: analysis of 305 cases of the European leukemia net registry","volume":"3","author":"Chelysheva","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.clml.2023.11.011_bib0059","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/blood-2019-124430","article-title":"Pregnancy management in CML patients: to treat or not to treat? Report of 224 outcomes of the European leukemia net (ELN) database","volume":"134","author":"Abruzzese","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0060","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1080\/10428194.2018.1551533","article-title":"The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia","volume":"60","author":"Lasica","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.11.011_bib0061","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3324\/haematol.2018.205054","article-title":"Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice","volume":"104","author":"Fava","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.11.011_bib0062","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/bjh.17392","article-title":"Successful tyrosine kinase inhibitor discontinuation outside clinical trials: data from the population-based Swedish chronic myeloid leukaemia registry","volume":"193","author":"Flygt","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0063","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ajh.26550","article-title":"Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors","volume":"97","author":"Haddad","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107367","article-title":"Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies","volume":"133","author":"Bhattacharjee","year":"2023","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0065","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00277-023-05280-9","article-title":"Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an indian tertiary care institution","volume":"102","author":"R","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0066","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00277-015-2317-z","article-title":"Managing pregnancy in chronic myeloid leukaemia","volume":"94","author":"Palani","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0067","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17474086.2023.2201429","article-title":"Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations","volume":"16","author":"Robertson","year":"2023","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0068","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1634\/theoncologist.2019-0109","article-title":"Planned pregnancy in female patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy","volume":"24","author":"Dou","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2023.11.011_bib0069","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1182\/blood-2018-99-115984","article-title":"Kinetics of the leukemic clone in patients with chronic myeloid leukemia during pregnancy","volume":"132","author":"Chelysheva","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0070","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood-2018-99-119615","article-title":"Kinetics of BCR-ABL after TKI interruption during pregnancy in CML: a multinational retrospective analysis","volume":"132","author":"Lee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0071","first-page":"1","article-title":"Digital PCR as a new method for minimal residual disease monitoring and treatment free remission management in chronic myeloid leukemia patients: is it reliable?","volume":"4","author":"Bernardi","year":"2022","journal-title":"Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0072","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.3390\/jcm9123865","article-title":"Molecular testing in CML between old and new methods: are we at a turning point?","volume":"9","author":"Soverini","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0073","first-page":"2867","article-title":"Standardization of two Dpcr platforms for detection of BCR\/ABL1: minimal residual disease (MRD) in Ph+ chronic myeloid leukemia (CML)","volume":"130","author":"Fava","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0074","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1159\/000510440","article-title":"RT-QPCR versus digital PCR: how do they impact differently on clinical management of chronic myeloid leukemia patients?","volume":"13","author":"Zanaglio","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ejh.13282","article-title":"\u201cVariant-specific discrepancy when quantitating BCR-ABL1 E13a2 and E14a2 transcripts using the Europe against cancer QPCR assay.\u201d Is DPCR the key?","volume":"103","author":"Bernardi","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0076","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/cancers15164112","article-title":"Minimal residual disease detection at RNA and leukemic stem cell (LSC) levels: comparison of RT-QPCR, d-PCR and CD26+ stem cell measurements in chronic myeloid leukemia (CML) patients in deep molecular response (DMR)","volume":"15","author":"Abruzzese","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clml.2023.11.011_bib0077","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/diseases9020035","article-title":"Alignment of Qx100\/Qx200 droplet digital (Bio-Rad) and QuantStudio 3D (thermofisher) digital PCR for quantification of BCR-ABL1 in Ph+ chronic myeloid leukemia","volume":"9","author":"Fava","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.clml.2023.11.011_bib0078","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/10428194.2016.1254779","article-title":"CML with pregnancy: real challenges in developing nations","volume":"58","author":"Sahu","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.11.011_bib0079","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12288-015-0519-0","article-title":"Obstetric complications and management in chronic myeloid leukemia","volume":"32","author":"Rohilla","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2023.11.011_bib0080","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.leukres.2013.07.020","article-title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","volume":"37","author":"Zhou","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0081","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3109\/10428194.2013.866662","article-title":"Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country","volume":"55","author":"Iqbal","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.11.011_bib0082","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2014.10.002","article-title":"Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre","volume":"39","author":"Alizadeh","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0083","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00277-023-05280-9","article-title":"Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution","volume":"102","author":"R","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0084","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11845-014-1084-5","article-title":"Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy","volume":"184","author":"Mukhopadhyay","year":"2015","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.clml.2023.11.011_bib0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/ejh.13215","article-title":"Risks and challenges of CML management during pregnancy: looking for a balanced decision","volume":"102","author":"Chelysheva","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0086","doi-asserted-by":"crossref","unstructured":"Broccia, G.; Casula, P.; Andria, M. Chronic myelocytic leukemia in pregnancy: report of a case treated with leukapheresis. 1984, 70, 371\u2013374, doi:10.1177\/030089168407000412.","DOI":"10.1177\/030089168407000412"},{"key":"10.1016\/j.clml.2023.11.011_bib0087","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1537-2995.1978.18178118555.x","article-title":"Management of chronic myelocytic leukemia in pregnancy by cell pheresis","volume":"18","author":"Caplan","year":"1978","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.clml.2023.11.011_bib0088","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.2830220213","article-title":"Leukapheresis for control of chronic myelogenous leukemia during pregnancy","volume":"22","author":"Fitzgerald","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0089","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajh.2830380316","article-title":"Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy","volume":"38","author":"Bazarbashi","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.11.011_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.transci.2015.05.009","article-title":"CML in pregnancy: a case report using leukapheresis and literature review","volume":"53","author":"Yellu","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.clml.2023.11.011_bib0091","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00404-008-0861-7","article-title":"Imatinib use during pregnancy and breast feeding: a case report and review of the literature","volume":"280","author":"Ali","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clml.2023.11.011_bib0092","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00404-007-0547-6","article-title":"Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report","volume":"278","author":"Buyukbayrak","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clml.2023.11.011_bib0093","article-title":"Chronic myeloid leukemia during pregnancy with placental involvement: case report and literature review","author":"Toru","year":"2023","journal-title":"Fetal Pediat Pathol"},{"key":"10.1016\/j.clml.2023.11.011_bib0094","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jjco\/hyh038","article-title":"Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature","volume":"34","author":"Ali","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clml.2023.11.011_bib0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3816\/CLM.2009.n.064","article-title":"Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature","volume":"9","author":"Cole","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clml.2023.11.011_bib0096","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4103\/0973-1482.119305","article-title":"Chronic myeloid leukemia with pregnancy: successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery","volume":"9","author":"Yadav","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.clml.2023.11.011_bib0097","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/AOG.0000000000001972","article-title":"Fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy","volume":"129","author":"Burwick","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clml.2023.11.011_bib0098","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/trf.15006","article-title":"Apheresis principles in a patient with chronic myeloid leukemia during pregnancy: challenges in cell separation and assessing transcript levels","volume":"59","author":"Lund","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.clml.2023.11.011_bib0099","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.leukres.2009.07.010","article-title":"BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant","volume":"34","author":"Salomon","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0100","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4081\/hr.2011.e27","article-title":"A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(Q34;Q11.2;Q13)","volume":"3","author":"Kumar","year":"2011","journal-title":"Hematol Rep"},{"key":"10.1016\/j.clml.2023.11.011_bib0101","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1447-0756.2011.01591.x","article-title":"Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy","volume":"37","author":"Eskander","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.clml.2023.11.011_bib0102","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/1078155220948942","article-title":"Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy","volume":"27","author":"Terao","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.clml.2023.11.011_bib0103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2147\/TCRM.S137103","article-title":"Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature","volume":"13","author":"Sgherza","year":"2017","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.clml.2023.11.011_bib0104","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jca.21410","article-title":"Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia","volume":"31","author":"Galera","year":"2016","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.clml.2023.11.011_bib0105","first-page":"147","article-title":"Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy","volume":"65","author":"Klaasen","year":"2007","journal-title":"Neth J Med"},{"key":"10.1016\/j.clml.2023.11.011_bib0106","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2018-99-115983","article-title":"Chronic myeloid leukemia diagnosed during pregnancy: therapy, outcomes and follow-up","volume":"132","author":"Chelysheva","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.11.011_bib0107","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood-2022-159993","article-title":"Chronic myeloid leukemia diagnosed during pregnancy: how to manage? Description of 86 cases from ELN international registry","volume":"140","author":"Chelysheva","year":"2022","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023021894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023021894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T22:14:12Z","timestamp":1712528052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023021894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2152265023021894"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.11.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: \u201cPer Aspera Ad Astra\u201d","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}